News on Alnylam Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Alnylam Pharmaceuticals news from BioPortfolio.com Tue, 09 Feb 2010 23:48:45 GMT en Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033438&HITNO=0&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033438&THISHREF=http://c.moreover.com/click/here.pl%3fz2535202516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033438&HITNO=0&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033438&THISHREF=http://c.moreover.com/click/here.pl%3fz2535202516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: News and FDA Updates for AdvanSource (NYSE:ASB), Advaxis (OTC:ADXS), Alnylam (Nasdaq:ALNY)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035382&HITNO=1&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035382&HITNO=1&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Getting the fat inhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032791&HITNO=2&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032791&THISHREF=http://c.moreover.com/click/here.pl%3fz2534823058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032791&HITNO=2&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032791&THISHREF=http://c.moreover.com/click/here.pl%3fz2534823058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: Alnylam Receives Notice of Allowance for US Patent Application on RNAi Agentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032248&HITNO=3&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032248&THISHREF=http://c.moreover.com/click/here.pl%3fz2534567099%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032248&HITNO=3&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032248&THISHREF=http://c.moreover.com/click/here.pl%3fz2534567099%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029111&HITNO=4&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029111&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029111&HITNO=4&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029111&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030883&HITNO=5&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030883&THISHREF=http://c.moreover.com/click/here.pl%3fz2533885793%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030883&HITNO=5&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030883&THISHREF=http://c.moreover.com/click/here.pl%3fz2533885793%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030112&HITNO=6&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030112&THISHREF=http://c.moreover.com/click/here.pl%3fz2533447501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030112&HITNO=6&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030112&THISHREF=http://c.moreover.com/click/here.pl%3fz2533447501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029202&HITNO=7&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029202&THISHREF=http://c.moreover.com/click/here.pl%3fz2533029153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029202&HITNO=7&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029202&THISHREF=http://c.moreover.com/click/here.pl%3fz2533029153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031632&HITNO=8&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031632&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031632&HITNO=8&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031632&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031579&HITNO=9&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031579&THISHREF=http://c.moreover.com/click/here.pl%3fz2534269557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031579&HITNO=9&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031579&THISHREF=http://c.moreover.com/click/here.pl%3fz2534269557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028933&HITNO=10&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028933&THISHREF=http://c.moreover.com/click/here.pl%3fz2532916292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028933&HITNO=10&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028933&THISHREF=http://c.moreover.com/click/here.pl%3fz2532916292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Alnylam Pharmaceuticals Downward Momentum Looks to Continue (ALNY)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017891&HITNO=11&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017891&THISHREF=http://c.moreover.com/click/here.pl%3fz2525351131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017891&HITNO=11&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017891&THISHREF=http://c.moreover.com/click/here.pl%3fz2525351131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: BIO Ventures for Global Health Chosen as Administrator of Intellectual Property Pool Involving GSK and Alnylamhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019092&HITNO=12&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019092&THISHREF=http://c.moreover.com/click/here.pl%3fz2526106949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019092&HITNO=12&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019092&THISHREF=http://c.moreover.com/click/here.pl%3fz2526106949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=13&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=13&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhoenix Business Journal: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=14&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=14&MSIZE=309&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Alnylam%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Finance: